SOCS3 and Alzheimer disease: Conversely, in the peripheral blood of AD patients, SOCS3 mRNA levels were elevated compared to those of healthy controls, and these levels were unchanged after the application of effective therapy, suggesting that SOCS3 is not associated with skin lesions but with maintaining the Th2-dominant phenotype in AD [116].